(Q84959068)
Statements
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer (English)
Sören Lehmann
Vladimir J N Bykov
Dina Ali
Ove Andrén
Honar Cherif
Ulf Tidefelt
Bertil Uggla
Jeffrey Yachnin
Gunnar Juliusson
Ali Moshfegh
Christer Paul
Per-Ola Andersson
10 September 2012